A Prospective Dose Finding Study of Iscador Infusion

NCT04376931 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Intravenous Solution

Sponsor

HaEmek Medical Center, Israel